Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
OLP-1002 by OliPass for Osteoarthritis Pain: Likelihood of Approval
OLP-1002 is under clinical development by OliPass and currently in Phase II for Osteoarthritis Pain. According to GlobalData, Phase II...